Because We Care.

Mr. Cyrille F. Buhrman joined the family business, Pacific Healthcare, in 1998 and eventually acquired the business in 2005. He successfully led the company into new business areas, including consumer health. He also successfully restructured the company and helped to establish strong foundations for sustainable and long-term growth.

He was a member of the Board of Directors at Canyon Pharmaceuticals from 2006-2010, as well as Soligenix Inc. from 2007-2010. With his international experience from the USA and Switzerland, he helped to make Pacific Healthcare a successful international brand within the healthcare industry, focusing on South East Asia and other developing markets around the world. He has brought together a strong leadership team with a proven track record.

Mr. Cyrille Buhrman attended Franklin University in Switzerland, where he studied history and political science, as well as economics and literature. He is a proud member of the Thailand Chapter of the Young Presidents Organization.

Mr. Patrik Bruhlmann brings a wealth of senior leadership experience across Asia Pacific and the Middle East, having held multiple Board and Chief Executive Officer roles in organizations with workforces of up to 3,000 employees.

Patrik joined the Group as Group CEO after spending five years in Australia, where he served as Chief Executive Officer of Vesture Limited, the second-largest property services provider in Australia.

Earlier in his career, he gained extensive experience in the pharmaceutical industry, spanning both retail and wholesale operations. From 1997 to 2010, he served as CEO at Zuellig Pharma in several markets, including Saudi Arabia, the Middle East, and Asia.

Patrik holds a Bachelor’s degree in Hotel Management from the prestigious École hôtelière de Lausanne (EHL Business School), Switzerland. He is also a graduate of two leading international business schools, having completed the Executive Program at INSEAD and earned an MBA from the National University of Singapore (NUS).

Jessie Tang brings with her for 33 years‘ experience from conglomerate business, financial services, and pharmaceutical distribution. With 25 years at Zuellig Pharma and played in numbers of senior management roles across the organization, she owned numbers of proven track records of achievement particularly in growing sales revenue from RM500 million to RM3.5 billion while being Chief Executive, Malaysia. She leaved her legacy at Zuellig Pharma with the final position of SVP, Executive Coaching.

She has a solid background with extensive experiences in financial and accounting, information technology, and client management. With her expertise and business acumen, she will strategically advise and assist Pacific Healthcare creating a dynamic path to build sustainable growth.

David Henderson brings an extensive finance, accounting and tax background, coupled with experience gained in operational and strategic areas of business to the board.

He is CEO of ROCG Asia Pacific with a career spanning over twenty years of providing advice to businesses around the globe.  David has worked with clients ranging from start-ups to listed businesses across a wide range of industries and locations with activities from acquisition, strategy, growth, cash flow and general business advisory.

With such expansive expertise, skills and qualifications, David’s strengths in financial and strategic management will assist in the achievement of new levels of business and shareholder value growth.

Mr. Waranon has over 20 years’ experience of in helping multinational corporations with complex financing and legal matters, regulatory matters, bankruptcy, M&A, and commercial law issues.

With years of practice experience in London, Hong Kong and Singapore, Warren is highly regarded for his advice both to foreign clients on challenging inbound investments and to domestic clients on their most complex business decisions.

Mr. Waranon has worked with many prestigious law firms and a wide range of colleagues and clients, in Bangkok and other major cities.

Ms. Audrey Schweitzer brings to the Board over 20 years of leadership experience in the healthcare and pharmaceutical industry, with a strong track record of leading multi-country operations across Europe, Asia, and Latin America. She has held senior executive roles at Ipsen, including General Manager positions in South Korea and Brazil, with full P&L responsibility, where she led business transformation and turnaround initiatives in highly regulated environments, particularly in oncology, rare diseases, and specialty care. She also brings experience in developing partnership-driven healthcare models in reproductive health. She combines deep expertise in commercial strategy, market access, and organisational leadership, with the ability to navigate complex, multicultural contexts. With her extensive international experience and proven leadership, Ms. Schweitzer’s strengths support sustainable business performance and long-term value creation.